Raise the Line’s in-depth look at the potential use of psychedelic compounds in mental health treatment continues today with a focus on the role they may play in helping people overcome substance use disorders. Our guest is Dr. Jeeshan Chowdhury, whose own mental health journey led him to found Journey Colab, a company combating addiction through psychedelic care while employing a unique stakeholder model that includes indigenous communities in ownership. “We have put 10% of the founding equity of the company into an irrevocable purpose trust so that the land, the traditions and the people that our medicines and our work are inspired from can benefit from it,” explains Chowdhury. He tells host Shiv Gaglani that indigenous traditions also inform how the company approaches psychedelic therapy itself. “When we look at their use, it is always done in the context of an expert healer, often called a shaman, and it's done as part of a very well-honed protocol and in the context of a larger community.” Check out this thoughtful discussion to find out why Chowdhury thinks of the therapeutic use of psychedelics as akin to surgery, and how Journey Colab is working with rehab center partners to integrate psychedelic care through clinical trials with the goal of creating an integrated treatment program.Mentioned in this episode: https://www.journeycolab.com